244 related articles for article (PubMed ID: 30572636)
21. Recent Advances in Biocompatible Ionic Liquids in Drug Formulation and Delivery.
Moshikur RM; Carrier RL; Moniruzzaman M; Goto M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111664
[TBL] [Abstract][Full Text] [Related]
22. Role and Recent Advancements of Ionic Liquids in Drug Delivery Systems.
Shukla MK; Tiwari H; Verma R; Dong WL; Azizov S; Kumar B; Pandey S; Kumar D
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840024
[TBL] [Abstract][Full Text] [Related]
23. Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids.
Lai A; Leong N; Zheng D; Ford L; Nguyen TH; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharm Res; 2022 Oct; 39(10):2405-2419. PubMed ID: 35661084
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Gastrointestinal Mucus Properties with Ionic Liquids for Drug Delivery.
Peng K; Gao Y; Angsantikul P; LaBarbiera A; Goetz M; Curreri AM; Rodrigues D; Tanner EEL; Mitragotri S
Adv Healthc Mater; 2021 Jul; 10(13):e2002192. PubMed ID: 34050617
[TBL] [Abstract][Full Text] [Related]
25. Solubility and stability of cytochrome c in hydrated ionic liquids: effect of oxo acid residues and kosmotropicity.
Fujita K; MacFarlane DR; Forsyth M; Yoshizawa-Fujita M; Murata K; Nakamura N; Ohno H
Biomacromolecules; 2007 Jul; 8(7):2080-6. PubMed ID: 17580947
[TBL] [Abstract][Full Text] [Related]
26. Ionic liquids as the effective technology for enhancing transdermal drug delivery: Design principles, roles, mechanisms, and future challenges.
Chen X; Li Z; Yang C; Yang D
Asian J Pharm Sci; 2024 Apr; 19(2):100900. PubMed ID: 38590797
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Solubility, Physicochemical Properties, and Cytotoxicity of Naproxen-Based Ionic Liquids.
Tang Y; Yang K; Zhao S; Chen Q; Qin L; Qin B
ACS Omega; 2023 Mar; 8(9):8332-8340. PubMed ID: 36910967
[TBL] [Abstract][Full Text] [Related]
28. Biocompatible ionic liquids: a new approach for stabilizing proteins in liquid formulation.
Vrikkis RM; Fraser KJ; Fujita K; Macfarlane DR; Elliott GD
J Biomech Eng; 2009 Jul; 131(7):074514. PubMed ID: 19640150
[TBL] [Abstract][Full Text] [Related]
29. Development of a w/o emulsion using ionic liquid strategy for transdermal delivery of anti - aging component α - lipoic acid: Mechanism of different ionic liquids on skin retention and efficacy evaluation.
Zhou Z; Liu C; Wan X; Fang L
Eur J Pharm Sci; 2020 Jan; 141():105042. PubMed ID: 31634554
[TBL] [Abstract][Full Text] [Related]
30. Ionic-Liquid-Based Paclitaxel Preparation: A New Potential Formulation for Cancer Treatment.
Chowdhury MR; Moshikur RM; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
Mol Pharm; 2018 Jun; 15(6):2484-2488. PubMed ID: 29762034
[TBL] [Abstract][Full Text] [Related]
31. An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.
de Almeida TS; Júlio A; Mota JP; Rijo P; Reis CP
Ther Deliv; 2017 Jun; 8(6):461-473. PubMed ID: 28530146
[TBL] [Abstract][Full Text] [Related]
32. From water-in-oil to oil-in-water emulsions to optimize the production of fatty acids using ionic liquids in micellar systems.
Santos LD; Coutinho JA; Ventura SP
Biotechnol Prog; 2015; 31(6):1473-80. PubMed ID: 26286754
[TBL] [Abstract][Full Text] [Related]
33. Ionic liquid based microemulsion with pharmaceutically accepted components: Formulation and potential applications.
Moniruzzaman M; Kamiya N; Goto M
J Colloid Interface Sci; 2010 Dec; 352(1):136-42. PubMed ID: 20825949
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for the enhanced stability of protein model compounds and peptide backbone unit in ammonium ionic liquids.
Vasantha T; Attri P; Venkatesu P; Devi RS
J Phys Chem B; 2012 Oct; 116(39):11968-78. PubMed ID: 22963600
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in exploiting ionic liquids for biomolecules: Solubility, stability and applications.
Sivapragasam M; Moniruzzaman M; Goto M
Biotechnol J; 2016 Aug; 11(8):1000-13. PubMed ID: 27312484
[TBL] [Abstract][Full Text] [Related]
36. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
[TBL] [Abstract][Full Text] [Related]
37. Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants.
Júlio A; Sultane A; Viana AS; Mota JP; Santos de Almeida T
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452124
[TBL] [Abstract][Full Text] [Related]
38. Ionic liquids as protein stabilizers for biological and biomedical applications: A review.
Veríssimo NV; Vicente FA; de Oliveira RC; Likozar B; Oliveira RPS; Pereira JFB
Biotechnol Adv; 2022 Dec; 61():108055. PubMed ID: 36374851
[TBL] [Abstract][Full Text] [Related]
39. Design of ionic liquids containing glucose and choline as drug carriers, finding the link between QM and MD studies.
Kalhor S; Fattahi A
Sci Rep; 2022 Dec; 12(1):21941. PubMed ID: 36535965
[TBL] [Abstract][Full Text] [Related]
40. Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein.
Grassiri B; Mezzetta A; Maisetta G; Migone C; Fabiano A; Esin S; Guazzelli L; Zambito Y; Batoni G; Piras AM
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
